INNOVITA's subsidiary recently obtained a qualification
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, INNOVITA announced that its wholly-owned subsidiary INNOVITA (Tangshan) Biotechnology Co., Ltd. (referred to as "Tangshan INNOVITA") has recently obtained a new product qualification, with the product name: Norovirus GI/GII Nucleic Acid Detection Kit (PCR Fluorescent Probe Method). The acquisition of this qualification broadens the variety of the company's products and further enhances the company's market expansion capabilities and core competitiveness
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments